We are live on ! Find out more
NTRP

Neurotrope, Inc. Common
NTRP

Delisted

NTRP was delisted on the 1st of December, 2020.

31 hedge funds and large institutions have $2.03M invested in Neurotrope, Inc. Common in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,700% more call options, than puts

Call options by funds: $88K | Put options by funds: $1K

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

16% more capital invested

Capital invested by funds: $1.75M → $2.03M (+$286K)

11% more funds holding

Funds holding: 2831 (+3)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
8
Increased
6
Reduced
4
Closed
5
Calls
$88K
Puts
$1K
Net Calls
+$87K
Net Calls Change
+$30K
Name Holding Trade Value Shares
Change
Change in
Stake
TI
26
tru Independence
Oregon
$2
AFM
27
Anson Funds Management
Texas
-$701K -855,440 Closed
FIA
28
FNY Investment Advisers
New York
-$61K -75,300 Closed
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
-$22.6K -18,084 Closed
Group One Trading
30
Group One Trading
Illinois
-$11.3K -9,037 Closed
Victory Capital Management
31
Victory Capital Management
Texas
-$4K -5,950 Closed
Simplex Trading
32
Simplex Trading
Illinois
-$5.03K -4,019 -90%
Wells Fargo
33
Wells Fargo
California
+$1 +1 +2%
JP Morgan Chase
34
JP Morgan Chase
New York
+$14 +11 New

NTRP Hedge Fund Activity: Q2 2020 in Review

31 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q2 2020, worth a combined $2.03M — up 16% from $1.75M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NTRP positions and 5 closed out — a net gain of 3 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $287K. The largest seller was Anson Funds Management, exiting entirely with an estimated $701K sold.

  • 31 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q2 2020, up from 28 in Q1 2020.
  • Funds reported $2.03M of Neurotrope, Inc. Common stock for Q2 2020, up 16% quarter-over-quarter.
  • 8 funds opened new Neurotrope, Inc. Common positions in Q2 2020 and 5 closed out, a net change of +3 holders.
  • The largest Neurotrope, Inc. Common buyer in Q2 2020 was Renaissance Technologies, an estimated $287K added.
  • The largest Neurotrope, Inc. Common seller in Q2 2020 was Anson Funds Management, an estimated $701K sold.

Based on aggregated 13F filings for Q2 2020.